Point/Counterpoint on Halting Implantation of the Subcutaneous ICD
JACC Clin Electrophysiol
.
2021 May;7(5):685-689.
doi: 10.1016/j.jacep.2021.03.006.
Epub 2021 Mar 12.
Authors
John Mandrola
1
,
Bogdan Enache
2
,
Raul Weiss
3
,
Emile G Daoud
4
Affiliations
1
Baptist Health Louisville, Louisville, Kentucky, USA. Electronic address: john.mandrola@gmail.com.
2
Victor Babes University of Medicine and Pharmacy, Timisoara, Romania; Department of Cardiology, Princess Grace Hospital, Monaco.
3
Cardiovascular Division, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Electronic address: raul.weiss@osumc.edu.
4
Cardiovascular Division, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
PMID:
33716205
DOI:
10.1016/j.jacep.2021.03.006
No abstract available
Keywords:
ICD; noninferiority trial; ventricular fibrillation.
Publication types
Editorial
MeSH terms
Defibrillators, Implantable*
Humans
Tachycardia, Ventricular*
Ventricular Fibrillation